FDA recall, , Low risk
LifeShare Blood Centers Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were distributed without documentation of arm inspection.
Recall ended Jun 4, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeShare Blood Centers recalled Red Blood Cells, Leukocytes Reduced, distributed in Arkansas, because the cells were collected from a donor who lacked documentation of arm inspection on the donor history questionnaire. The recall began on April 9, 2025, and was added to the FDA's Enforcement Report on June 4, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeShare Blood Centers
- Hazard
- Blood donor screening
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 98799
- Recall number
- B-0071-2026
All recalls from LifeShare Blood Centers
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
